AAAAAA

   
Results: 1-13 |
Results: 13
BRCA1 AND BRCA2 MUTATIONS IN BELGIAN FAMILIES WITH A HISTORY OF BREAST AND OR OVARIAN/
Authors: SIBILLEHOANG C FROMENT O DETERBEERST AJ LEPIECE V HUBERLANT G BLAUWAERT G VINDEVOGHEL A CANON JL GILLEROT Y
Citation: C. Sibillehoang et al., BRCA1 AND BRCA2 MUTATIONS IN BELGIAN FAMILIES WITH A HISTORY OF BREAST AND OR OVARIAN/, European journal of cancer prevention, 7, 1998, pp. 3-5
A DOUBLE RANDOMIZED TRIAL ON PORTAL AND SYSTEMIC CHEMOTHERAPY FOR DUKES B2 AND C COLORECTAL-CANCER - A 3 YEARS REPORT ON A DOUBLE RANDOMIZED TRIAL
Authors: FOCAN C BURY J BEAUDUIN M HERMAN ML VINDEVOGHEL A LECOMTE M BROHEE D CANON JL
Citation: C. Focan et al., A DOUBLE RANDOMIZED TRIAL ON PORTAL AND SYSTEMIC CHEMOTHERAPY FOR DUKES B2 AND C COLORECTAL-CANCER - A 3 YEARS REPORT ON A DOUBLE RANDOMIZED TRIAL, Annals of oncology, 9, 1998, pp. 159-159
PROPHYLACTIC USE OF ANTIBIOTICS DURING TREATMENT WITH CPT-11 (CAMPTO(R)) FOR METASTATIC COLORECTAL-CANCER [MCC] - A RANDOMIZED MULTICENTER TRIAL
Authors: STUPP R FOCAN C SESSA C NOWACKI M VANDENBOSSCHE G CANON JL ZALUSKI J OULIDAISSA D BOUSSARD B PESTALOZZI B
Citation: R. Stupp et al., PROPHYLACTIC USE OF ANTIBIOTICS DURING TREATMENT WITH CPT-11 (CAMPTO(R)) FOR METASTATIC COLORECTAL-CANCER [MCC] - A RANDOMIZED MULTICENTER TRIAL, Annals of oncology, 9, 1998, pp. 163-163
ISOLATION OF CD34(-CELL DEPLETION OF PERIPHERAL-BLOOD STEM-CELLS FROMBREAST-CANCER PATIENTS() CELLS WITH THE AMGEN CELL SELECTION SYSTEM PROVIDES T, NK AND TUMOR)
Authors: SYMANN M GUILLAUME T SALMON M BRIDDELL R ZILM K CANON JL ANDRE M JURDAN M JOHNSEN H RICHEL D MYLTENYI S EWEN C MCNIECE I
Citation: M. Symann et al., ISOLATION OF CD34(-CELL DEPLETION OF PERIPHERAL-BLOOD STEM-CELLS FROMBREAST-CANCER PATIENTS() CELLS WITH THE AMGEN CELL SELECTION SYSTEM PROVIDES T, NK AND TUMOR), Experimental hematology, 25(8), 1997, pp. 254-254
EFFICIENCY OF HIGH-DOSE FEC CHEMOTHERAPY FOR MOBILIZING HEMATOPOIETICSTEM-CELLS INTO PERIPHERAL-BLOOD
Authors: DHONDT L ANDRE M CANON JL GUILLAUME T DOYEN C FEYENS AM CHATELAIN B DROMELET A HUMBLET Y LONGUEVILLE J SYMANN M
Citation: L. Dhondt et al., EFFICIENCY OF HIGH-DOSE FEC CHEMOTHERAPY FOR MOBILIZING HEMATOPOIETICSTEM-CELLS INTO PERIPHERAL-BLOOD, Bulletin du cancer, 84(7), 1997, pp. 729-733
A RANDOMIZED PILOT CLINICAL-TRIAL COMPARING 5 VERSUS 10 MU-G KG FILGRASTIM (NEUPOGEN) AFTER FEC CHEMOTHERAPY IN ORDER TO COLLECT PERIPHERAL-BLOOD STEM-CELLS (PBSC)/
Authors: DHONDT L ANDRE M GUILLAUME T FEYENS AM CANON JL DOYEN C HUMBLET Y LONGUEVILLE J VANNEROM H SYMANN M
Citation: L. Dhondt et al., A RANDOMIZED PILOT CLINICAL-TRIAL COMPARING 5 VERSUS 10 MU-G KG FILGRASTIM (NEUPOGEN) AFTER FEC CHEMOTHERAPY IN ORDER TO COLLECT PERIPHERAL-BLOOD STEM-CELLS (PBSC)/, European journal of cancer, 31A, 1995, pp. 355-355
OPTIMAL COMBINATION THERAPY WITH NAVOBAN(R) (TROPISETRON) IN PATIENTSWITH INCOMPLETE CONTROL OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING
Authors: VANBELLE SJP COCQUYT VFJ BLEIBERG H CANON JL BUYSE M HULSTAERT F DEWITTE M DEKEYSER P WESTELINCK K
Citation: Sjp. Vanbelle et al., OPTIMAL COMBINATION THERAPY WITH NAVOBAN(R) (TROPISETRON) IN PATIENTSWITH INCOMPLETE CONTROL OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING, Anti-cancer drugs, 6, 1995, pp. 22-30
TUMOR-REGRESSION RESPONSES IN MELANOMA PATIENTS TREATED WITH A PEPTIDE ENCODED BY GENE MAGE-3
Authors: MARCHAND M WEYNANTS P RANKIN E ARIENTI F BELLI F PARMIANI G CASCINELLI N BOURLOND A VANWIJCK R HUMBLET Y CANON JL LAURENT C NAEYAERT JM PLAGNE R DERAEMAEKER R KNUTH A JAGER E BRASSEUR F HERMAN J COULIE PG BOON T
Citation: M. Marchand et al., TUMOR-REGRESSION RESPONSES IN MELANOMA PATIENTS TREATED WITH A PEPTIDE ENCODED BY GENE MAGE-3, International journal of cancer, 63(6), 1995, pp. 883-885
2-CHLORODEOXYADENOSINE IN REFRACTORY NON-HODGKINS-LYMPHOMA - A PHASE-II STUDY ON 50 PATIENTS
Authors: BOSLY A SONET A FERRANT A DELANNOY A CORNU G CANON JL MARTIAT P STRAETMANS N RAVOET C MINEUR P LASZLO C JAMART J DOYEN C MICHAUX JL
Citation: A. Bosly et al., 2-CHLORODEOXYADENOSINE IN REFRACTORY NON-HODGKINS-LYMPHOMA - A PHASE-II STUDY ON 50 PATIENTS, Blood, 86(10), 1995, pp. 212-212
2-CHLORODEOXYADENOSINE (CDA) THERAPY IN CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) AND WALDENSTROMS MACROGLOBULINEMIA (WD) - AN UPDATE ON 77 PATIENTS
Authors: MAEREVOET M DELANNOY A FERRANT A BOSLY A MARTIAT P MINEUR P CANON JL ZENEBERGH A MICHAUX JL
Citation: M. Maerevoet et al., 2-CHLORODEOXYADENOSINE (CDA) THERAPY IN CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) AND WALDENSTROMS MACROGLOBULINEMIA (WD) - AN UPDATE ON 77 PATIENTS, Blood, 86(10), 1995, pp. 3338-3338
FATAL CANDIDA-FAMATA PERITONITIS IN A PATIENT UNDERGOING CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS WHO WAS TREATED WITH FLUCONAZOLE
Authors: QUINDOS G CABRERA F ARILLA MD BURGOS A ORTIZVIGON R CANON JL PONTON J
Citation: G. Quindos et al., FATAL CANDIDA-FAMATA PERITONITIS IN A PATIENT UNDERGOING CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS WHO WAS TREATED WITH FLUCONAZOLE, Clinical infectious diseases, 18(4), 1994, pp. 658-660
OPTIMAL COMBINATION THERAPY WITH TROPISETRON IN 445 PATIENTS WITH INCOMPLETE CONTROL OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING
Authors: HULSTAERT F VANBELLE S BLEIBERG H CANON JL DEWITTE M BUYSE M DEKEYSER P WESTELINCK KJ
Citation: F. Hulstaert et al., OPTIMAL COMBINATION THERAPY WITH TROPISETRON IN 445 PATIENTS WITH INCOMPLETE CONTROL OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING, Journal of clinical oncology, 12(11), 1994, pp. 2439-2446
DOSE-DEPENDENT INTERLEUKIN-3 STIMULATION OF THROMBOPOIESIS AND NEUTROPOIESIS IN PATIENTS WITH SMALL-CELL LUNG-CARCINOMA BEFORE AND FOLLOWING CHEMOTHERAPY - A PLACEBO-CONTROLLED RANDOMIZED PHASE-IB STUDY
Authors: DHONDT V WEYNANTS P HUMBLET Y GUILLAUME T CANON JL BEAUDUIN M DUPREZ P LONGUEVILLE J MULL R CHATELAIN C SYMANN M
Citation: V. Dhondt et al., DOSE-DEPENDENT INTERLEUKIN-3 STIMULATION OF THROMBOPOIESIS AND NEUTROPOIESIS IN PATIENTS WITH SMALL-CELL LUNG-CARCINOMA BEFORE AND FOLLOWING CHEMOTHERAPY - A PLACEBO-CONTROLLED RANDOMIZED PHASE-IB STUDY, Journal of clinical oncology, 11(11), 1993, pp. 2063-2071
Risultati: 1-13 |